Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 30523719

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2019 Jan 20
First author
Sha C

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Jan 20;37(3):175-177. doi: 10.1200/JCO.18.01910.
    note
    Source null
    related pmid
    30523718
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Apr 20;37(12):1035. doi: 10.1200/JCO.19.00581.
    note
    Source null
    related pmid
    30995418
    relationship
    Erratum in

Authors and identifiers

  1. name
    Sha C
    type
    Author
  2. name
    Barrans S
    type
    Author
  3. name
    Cucco F
    type
    Author
  4. name
    Bentley MA
    type
    Author
  5. name
    Care MA
    type
    Author
  6. name
    Cummin T
    type
    Author
  7. name
    Kennedy H
    type
    Author
  8. name
    Thompson JS
    type
    Author
  9. name
    Uddin R
    type
    Author
  10. name
    Worrillow L
    type
    Author
  11. name
    Chalkley R
    type
    Author
  12. name
    van Hoppe M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sha C
    type
    Author
  2. name
    Barrans S
    type
    Author
  3. name
    Cucco F
    type
    Author
  4. name
    Bentley MA
    type
    Author
  5. name
    Care MA
    type
    Author
  6. name
    Cummin T
    type
    Author
  7. name
    Kennedy H
    type
    Author
  8. name
    Thompson JS
    type
    Author
  9. name
    Uddin R
    type
    Author
  10. name
    Worrillow L
    type
    Author
  11. name
    Chalkley R
    type
    Author
  12. name
    van Hoppe M
    type
    Author
bibliography ids
  1. nci-bib-fb1bb628dca99bb04035f7f6
book metadata
content sha256
8b30291640841cf7794e744b407757d31c420020a8090d047c35981baaf4a85e
document type
citation
dois
  1. 10.1200/JCO.18.01314
electronic publication date
display
2018 Dec 3
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30523719
immutable id
pubmed:30523719@8b30291640841cf7794e744b407757d31c420020a8090d047c35981baaf4a85e
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
3
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
202-212
volume
37
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Jan 20;37(3):175-177. doi: 10.1200/JCO.18.01910.
    note
    Source null
    related pmid
    30523718
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Apr 20;37(12):1035. doi: 10.1200/JCO.19.00581.
    note
    Source null
    related pmid
    30995418
    relationship
    Erratum in
outcomes validated
false
pmid
30523719
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
f4a7a06b6ce271bd8bd77d35b95ab1414a76a1175f154757389e3a2019331139
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2019 Jan 20
precision
day
year
2019
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30523719/
title
Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.

Preserved source evidence · Independent clinical review pending · Not medical advice